Back to Journals » OncoTargets and Therapy » Volume 9

Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma

Total article views   HTML views PDF downloads Totals
6,699 Dovepress* 6,195+ 1,323 7,518
PubMed Central* 504 185 689
Totals 6,699 1,508 8,207
*Since 25 July 2016

View citations on PubMed Central and Google Scholar